BioCardia (NASDAQ:BCDA) reported its Q4 earnings results on Wednesday, March 27, 2024 at 04:00 AM.
Here’s what investors need to know about the announcement.
Earnings
BioCardia beat estimated earnings by 18.0%, reporting an EPS of $-0.09 versus an estimate of $-0.11.
Revenue was down $93 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 6.0% drop in the share price the next day.
Here’s a look at BioCardia’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.12 | -0.16 | -0.16 | -0.18 |
| EPS Actual | -0.12 | -0.17 | -0.17 | -0.16 |
| Revenue Estimate | 20K | 120K | 340K | 100K |
| Revenue Actual | 357K | 43K | 64K | 106K |
To track all earnings releases for BioCardia visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
